Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    23964934 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Interventions: Drug: Pazopanib;   Drug: Sunitinib
2 Recruiting Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery
Condition: Clear-cell Metastatic Renal Cell Carcinoma
Interventions: Drug: sunitinib or pazopanib;   Procedure: Cytoreductive nephrectomy

Study has passed its completion date and status has not been verified in more than two years.